• Q3 revenue was down 62% YoY, and 16% QoQ, beating our estimate by 14%. EPS was 6% higher than our estimate.
          • This report is currently available to premium subscribers – Free subscribers will gain access on Nov 30th, 2022 Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit Goodbody Health Inc. page for more research, discussion boards and to like, and share.

Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In